Cargando…

Nighttime home blood pressure lowering effect of esaxerenone in patients with uncontrolled nocturnal hypertension: the EARLY-NH study

There is limited evidence on the blood pressure (BP)-lowering effect of esaxerenone on home BP, including nighttime BP. Using two newly developed nocturnal home BP monitoring devices (brachial and wrist), this multicenter, open-label, prospective study investigated the nighttime home BP-lowering eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kario, Kazuomi, Nishizawa, Masafumi, Kato, Mitsutoshi, Ishii, Hajime, Uchiyama, Kazuaki, Nagai, Michiaki, Takahashi, Nobuo, Asakura, Taro, Shiraiwa, Toshihiko, Yoshida, Tetsuro, Kaneshiro, Mizuki, Taguchi, Takashi, Shiosakai, Kazuhito, Sugimoto, Kotaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319630/ https://www.ncbi.nlm.nih.gov/pubmed/37173430 http://dx.doi.org/10.1038/s41440-023-01292-0

Ejemplares similares

Effect of esaxerenone on nocturnal blood pressure and natriuretic peptide in different dipping phenotypes
por: Kario, Kazuomi, et al.
Publicado: (2021)

Rationale and design of a multicenter randomized study comparing the efficacy and safety of esaxerenone versus trichlormethiazide in patients with uncontrolled essential hypertension: EXCITE‐HT study
por: Kario, Kazuomi, et al.
Publicado: (2023)

Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study
por: Kario, Kazuomi, et al.
Publicado: (2020)

Comparison of nighttime measurement schedules using a wrist‐type nocturnal home blood pressure monitoring device
por: Tomitani, Naoko, et al.
Publicado: (2021)

Reproducibility of nighttime home blood pressure measured by a wrist‐type nocturnal home blood pressure monitoring device
por: Tomitani, Naoko, et al.
Publicado: (2021)

Twenty-Four-Hour Blood Pressure–Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension: Results From the Randomized, Placebo-Controlled SACRA Study
por: Kario, Kazuomi, et al.
Publicado: (2019)

Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study
por: Uchida, Haruhito A., et al.
Publicado: (2022)

Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice: The J-HOP Nocturnal Blood Pressure Study
por: Kario, Kazuomi, et al.
Publicado: (2019)

Sleep and nocturnal hypertension: Genes, environment, and individual profiles
por: Kario, Kazuomi
Publicado: (2022)

Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetes Mellitus Undergoing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors (EAGLE-DH)
por: Motoki, Hirohiko, et al.
Publicado: (2023)

A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine Treatment for Hypertension in the Early Morning (At-HOME) Study
por: Kario, Kazuomi, et al.
Publicado: (2010)

Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study
por: Kario, Kazuomi, et al.
Publicado: (2020)

Association of lower nighttime diastolic blood pressure and hypoxia with silent myocardial injury: The Japan Morning Surge‐Home Blood Pressure study
por: Kubota, Kana, et al.
Publicado: (2020)

Rationale and Design of the Efficacy and Safety of Esaxerenone in Hypertensive Patients With Left Ventricular Hypertrophy (ESES-LVH) Study　― Protocol for a Multicenter, Open-Label, Exploratory Interventional Study ―
por: Sueta, Daisuke, et al.
Publicado: (2022)

Study of Sustained Blood Pressure-Lowering Effect of Azelnidipine Guided by Self-Measured Morning and Evening Home Blood Pressure: Subgroup Analysis of the At-HOME Study
por: Kario, Kazuomi, et al.
Publicado: (2013)

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
por: Kario, Kazuomi, et al.
Publicado: (2013)

Nocturnal blood pressure surge in seconds is associated with arterial stiffness independently of conventional nocturnal blood pressure variability in suspected obstructive sleep apnea patients
por: Kokubo, Ayako, et al.
Publicado: (2023)

Comparative effects of valsartan plus cilnidipine or hydrochlorothiazide on nocturnal home blood pressure
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

Renoprotective Effect of the Mineralocorticoid Receptor Antagonist Esaxerenone
por: Oshima, Akira, et al.
Publicado: (2021)

Visit‐to‐visit office blood pressure variability revisited in SPRINT
por: Nagai, Michiaki, et al.
Publicado: (2021)

Antihypertensive Effects of Esaxerenone in Older Patients with Primary Aldosteronism
por: Fujimoto, Masanori, et al.
Publicado: (2023)

Nocturnal blood pressure surge in seconds is a new determinant of left ventricular mass index
por: Kokubo, Ayako, et al.
Publicado: (2021)

Sleep Duration as a Risk Factor for Cardiovascular Disease- a Review of the Recent Literature
por: Nagai, Michiaki, et al.
Publicado: (2010)

Day‐to‐day blood pressure variability and severity of COVID‐19: Is sympathetic overdrive a potential link?
por: Nagai, Michiaki, et al.
Publicado: (2021)

Short- and Long-Term Reproducibility of Nighttime Blood Pressure Phenotypes and Nocturnal Blood Pressure Reduction
por: Mancia, Giuseppe, et al.
Publicado: (2021)

Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
por: Kirigaya, Yoshiaki, et al.
Publicado: (2020)

Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction
por: Ito, Sadayoshi, et al.
Publicado: (2020)

Simultaneous self‐monitoring comparison of a supine algorithm‐equipped wrist nocturnal home blood pressure monitoring device with an upper arm device
por: Kario, Kazuomi, et al.
Publicado: (2021)

Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

Clinical Significance and Therapeutic Implication of Nocturnal Hypertension: Relationship between Nighttime Blood Pressure and Quality of Sleep
por: Cho, Myeong-Chan
Publicado: (2019)

Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone
por: Rakugi, Hiromi, et al.
Publicado: (2020)

Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males
por: Toyama, Kaoru, et al.
Publicado: (2021)

Validation of a wrist‐type home nocturnal blood pressure monitor in the sitting and supine position according to the ANSI/AAMI/ISO81060‐2:2013 guidelines: Omron HEM‐9601T
por: Kuwabara, Mitsuo, et al.
Publicado: (2020)

Impaired Daytime Urinary Sodium Excretion Impacts Nighttime Blood Pressure and Nocturnal Dipping at Older Ages in the General Population
por: Del Giorno, Rosaria, et al.
Publicado: (2020)

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
por: Kario, Kazuomi, et al.
Publicado: (2022)

Nighttime Encounter
por: Sampson, Samuel
Publicado: (2015)

Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment
por: Kurata, Akifumi, et al.
Publicado: (2019)

Implication of Mineralocorticoid Receptor Antagonist Esaxerenone in Patients With Heart Failure With Preserved Ejection Fraction
por: Imamura, Teruhiko, et al.
Publicado: (2021)

A Case of a Pregnant Woman With Primary Aldosteronism and Superimposed Preeclampsia Treated With Esaxerenone
por: Yamashita, Kaoru, et al.
Publicado: (2022)

Daytime nap and nighttime breastfeeding are associated with toddlers’ nighttime sleep
por: Nakagawa, Machiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mnks4qq0tdaoa18kbj1q9cosaq